- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Scientific Poster Download
Poster modified on 13/12/2023
Optimizing Bispecific Antibody Production: Strategies for Improved Purity and Yield
Gaozhan Zhang, Li Zhang, Dawei Zhang, Mengjie Lu, Zhumei Feng, Jiansheng Wu
WuXi Biologics, NO.240 Hedan Road, Pudong New District, Shanghai, China
Bispecific antibodies (BsAbs) are a rapidly evolving and promising category of biotherapeutics. Unlike monoclonal antibodies, the production of bsAbs presents significant challenges in terms of quantity, quality, and stability, which could potentially limit their wider adoption in clinical applications. At WuXi Biologics, our Protein Sciences (PS) Department has developed integrated strategies to overcome these challenges in bsAb production.
This scientific poster was originally presented during the 2023 AET conference
Discuss This Poster
To discuss the data in this poster, please complete the form on the following page to connect with our experts.